Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.
Our trusted Pharma Intelligence brands
Pharmaprojects
Our world was disrupted at warp speed during 2020. Are you ready to gain a deeper understanding of the year that changed our perceptions of possible?
Biomedtracker
This is both an updated study of clinical drug development success rates from our 2016 report, and an expansion into the drivers of success with the addition of machine learning modeling to analyze the predictive factors contributing to drug development.
Topic Clinical Trials Drug Development Landscape Drug Pricing
Scrip
For Scrip’s annual preview our journalists asked over 200 industry executives and experts for their predictions of the major trends for 2021. From the pandemic, to AI, therapeutics, and the new US leadership, here’s what to watch out for – in a year with so much at stake.
Citeline Engage
Ignite awareness of your clinical trial with featured sponsorships and email campaigns to boost physician awareness and patient enrollment
Topic Clinical Trials
Citeline Engage
Recruit experienced investigators or trial-naïve physicians to participate in clinical research. Establish peer-to-peer connections between investigators and physicians after site activation to support patient referrals
Topic Clinical Trials
Citeline Engage
Virtually gather healthcare professionals to collaborate on your critical business topics
Citeline
Improve your clinical trial decisions and cycle times
Topic Clinical Trials
Medtech Insight
As the US embarks on a new era in leadership, changes in regulatory, policy, manufacturing and supply chains of medical devices and diagnostics will take place. What changes in the US medtech market can we expect to see over the next four years?
Topic Medtech
Medtech Insight
As the US embarks on a new era in leadership, changes in regulatory, policy, manufacturing and supply chains of medical devices and diagnostics will take place. What changes in the medtech market can we expect to see over the next four years?
Topic Medtech
Scrip
Join us for an audio catch-up on the major events in the global biopharma industry over the past business week, as reported by Scrip's worldwide team, in this podcast version of Five Must-Know Things.
Scrip
A strong year is predicted for biopharma business with investment and deal making set to continue apace. Executives across industry share their forecasts for the year ahead.
Scrip
The current coronavirus vaccines focus on the spike protein but the UK's Scancell believes it has a candidate that also targets the SARS-CoV-2 nucleocapsid protein which could help tackle existing and future variants.
Scrip
After disappointing initially, Lilly and Regeneron are back with compelling data for their monoclonal antibody products, but still face challenges from new COVID-19 variants and medical skepticism.
Scrip
White said the late 2019 creation of Loxo Oncology at Lilly to spearhead cancer R&D has exceeded her expectations. The executive also discussed COVID-19’s impact on drug sales and cancer screening.
Scrip
Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.
Medtech Insight
08 Mar 2021
Scrip
08 Mar 2021
HBW Insight
07 Mar 2021
Scrip
05 Mar 2021
Medtech Insight
05 Mar 2021
Medtech Insight
05 Mar 2021
Pink Sheet
05 Mar 2021
Scrip
05 Mar 2021
Generics Bulletin
05 Mar 2021
Medtech Insight
05 Mar 2021
Medtech Insight
05 Mar 2021
Pink Sheet
05 Mar 2021
Scrip
05 Mar 2021
Generics Bulletin
05 Mar 2021
Scrip
05 Mar 2021
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.
Key benefits:
Key benefits:
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
